The life sciences real estate landscape is at an inflection point as we move through 2026. After several years of market correction, early signs of recovery are emerging as demand returns and capital flows improve. However, persistent oversupply continues to create a highly competitive, tenant-favorable environment. What does this mean for investors, owners and life sciences companies navigating these evolving conditions?
The 2026 U.S. Lab Property Report reveals six trends shaping today’s lab market dynamics. Availability is beginning to contract, but elevated supply levels continue to pressure rents and reshape leasing activity. At the same time, tenant preferences are shifting, demand is rebounding in top markets and new occupier groups are redefining how lab space is used.
